Highlights of ASH 2021
New This Year! Hybrid Course!
Attend in-person or virtually
The field of hematology has been rapidly evolving. This continuing medical education activity will discuss new developments in the diagnosis and treatment of malignant and non malignant hematological disorders, as presented at the 2021 Annual Meeting of the American Society of Hematology (ASH). At this one-day course, faculty will share the latest updates in myeloid malignancies, lymphoma, leukemia, multiple myeloma, coagulation disorders, and stem cell transplantation. Through presentations and Q & A, attendees will gain a deeper understanding of emerging treatments available for hematological malignancies and blood disorders and learn how these new therapies can be integrated into daily practice.
This conference is intended for primary care physicians, hematologists and medical oncologists, fellows, residents, CRNP’s, PA’s, nurses and all other healthcare providers.
Salman Fazal, MD
Assistant Professor, Temple University School of Medicine
Director, Cell Transplantation Program
Allegheny Health Network Cancer Institute
West Penn Hospital
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Allegheny General Hospital and Allegheny Health Network Cancer Institute West Penn Hospital. Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Approved for AMA PRA Category 1 TM Credits. Credits to be determined.